Impaired fibrinolytic activity in defined chronic back pain syndromes.
Fibrinolytic activity was studied in 34 patients who had chronic low-back pain of defined types (spondylosis, post-laminectomy and postmyelography-proven arachnoiditis, postlaminectomy and postmyelography-possible arachnoiditis, chronic prolapsed intervertebral disc (PID), spinal stenosis, and nonspecific low-back pain). Fibrinolysis was significantly impaired in the back pain patients as a whole compared with matched controls. Similar changes were observed in all the different back pain syndromes. In the smaller subgroups, these did not reach significance but were significant in spondylosis, proven arachnoiditis, and nonspecific back pain. It is suggested that the abnormal persistence of a defect in fibrinolytic activity, leading to fibrin deposition and chronic inflammation, may be an important factor in the chronicity of many back pain syndromes.
D000328:Adult; D000368:Aged; D001100:Arachnoiditis / Q000097:blood; D001416:Back Pain / Q000097:blood*; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000097:blood; D008297:Male; D008875:Middle Aged; D013128:Spinal Osteophytosis / Q000097:blood; D013130:Spinal Stenosis / Q000097:blood